Increasing survival in HCV-related hepatocellular carcinoma

被引：3
|
作者：
Ray K.
机构：
[1] Nature Reviews Gastroenterology & Hepatology,
来源：
Nature Reviews Gastroenterology & Hepatology | 2019年 / 16卷 / 10期
关键词：
D O I：
10.1038/s41575-019-0202-2
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：582 / 582
相关论文
共 50 条
  • [41] Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments
    Sypsa, V
    Touloumi, G
    Papatheodoridis, GV
    Tassopoulos, NC
    Ketikoglou, I
    Vafiadis, I
    Hatzis, G
    Tsantoulas, D
    Akriviadis, E
    Koutsounas, S
    Hatzakis, A
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 : 84 - 84
  • [42] PREDICTIVE FACTORS OF DISTANT RECURRENCE OF HCV-RELATED HEPATOCELLULAR CARCINOMA AFTER RADIOFREQUENCY ABLATION
    Beppu, Tetsuya
    Shiraki, Katsuya
    Sugimoto, Kazushi
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Tanaka, Junichiro
    Yamamoto, Norihiko
    Tameda, Masahiko
    Takei, Yoshiyuki
    [J]. HEPATOLOGY, 2010, 52 (04) : 1191A - 1192A
  • [43] LNCRNA H19 Is Increased In Hepatocellular Carcinoma With Underlying Hcv-Related Cirrhosis
    Garcia-Valdecasas, Marta
    Gil-Gomez, Antonio
    Rojas, Angela
    Gallego-Duran, Rocio
    Munoz, Rocio
    Fombuena, Blanca
    Pastor-Ramirez, Helena
    Del Campo, Jose A.
    Vilar-Gomez, Eduardo
    Ampuero, Javier
    Romero-Gomez, Manuel
    [J]. HEPATOLOGY, 2016, 64 : 970A - 970A
  • [44] The management strategies for HCV-related early hepatocellular carcinoma: A health decision analysis.
    Moriguchi, H
    [J]. HEPATOLOGY, 2002, 36 (04) : 710A - 710A
  • [45] Serum VEGF as a Tumor Marker for Patients With HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma
    Mukozu, Takanori
    Nagai, Hidenari
    Kobayashi, Koujirou
    Ogino, Yu
    Matui, Daigo
    Kanekawa, Takenori
    Kogame, Michio
    Takayama, Ryuji
    Kanayama, Masahiro
    Wakui, Noritaka
    Shinohara, Mie
    Shinohara, Masao
    Ishii, Koji
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S980 - S980
  • [46] HCV-related hepatocellular carcinogenesis and treatment of liver cirrhosis
    Ikeda, K
    Kumada, H
    [J]. PROGRESS IN HEPATOLOGY, VOL 2: INTERFERON THERAPY ON CHRONIC HEPATITIS C, 1996, 1113 : 55 - 59
  • [47] Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma
    Hsu, Ching-Sheng
    Chao, You-Chen
    Lin, Hans Hsienhong
    Chen, Ding-Shinn
    Kao, Jia-Horng
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [48] A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis
    Nahon, Pierre
    Sutton, Angela
    Rufat, Pierre
    Charnaux, Nathalie
    Mansouri, Abdellah
    Moreau, Richard
    Ganne-Carrie, Nathalie
    Grando-Lemaire, Veronique
    N'Kontchou, Gisele
    Trinchet, Jean-Claude
    Pessayre, Dominique
    Beaugrand, Michel
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 (02) : 426 - 432
  • [49] Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma
    De Mitri, MS
    Mele, L
    Chen, CH
    Piccinini, A
    Chianese, R
    D'Errico, A
    Alberti, A
    Pisi, E
    [J]. JOURNAL OF HEPATOLOGY, 1998, 29 (06) : 887 - 892
  • [50] Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China
    Li, Xu
    Xu, Hongqin
    Ding, Zhongyang
    Jin, Qinglong
    Gao, Pujun
    [J]. MEDICINE, 2016, 95 (49) : e5587
12345